Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Journal of Environmental Pathology, Toxicology and Oncology
Impact-faktor: 1.241 5-jähriger Impact-Faktor: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Druckformat: 0731-8898
ISSN Online: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v28.i3.20
pages 209-221

Regulation of Heme Synthesis and Proteasomal Activity by Copper: Possible Implications for Wilson's Disease

Ravit Hait-Darshan
The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel
Tania Babushkin
The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel
Zvi Malik
The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Israel

ABSTRAKT

Wilson's disease (Wd) is a genetic disorder resulting in Cu2+ accumulation, and is caused by mutations in the ATP7B gene, the copper transporter. In vivo studies show a correlation between Cu2+ accumulation and malfunction of the heme biosynthesis pathway. In this study, we describe multiple effects of Cu2+ accumulation on heme synthesis, which, in turn, affect proteasomal activity. Cu2+ toxicity was examined in two hepatocellular carcinoma cell lines, HepG2 and Hep3B, with Hep3B cells containing an integrated hepatitis B virus genome. Exposure of HepG2 and Hep3B cells to Cu2+ inhibited the enzymes PBGD and ALAD of the heme synthesis pathway and, in parallel, upregulated heme oxygenase-1 (HO-1). Proto-porphyrin IX (PpIX) and the heme pool were reduced as a result of these processes. PpIX synthesis was found to be lower in cells expressing the mutant ATP7B (P1134P), compared to those expressing the WT enzyme. Proteasomal activity was inhibited under Cu2+ treatment in HepG2 cells; however, Cu2+ induced marked proteosomal acceleration in Hep3B cells. Under these conditions, Ub-conjugated proteins were gradually accumulated, whereas treatment with bathocuproine disulfonic acid (BCS), a Cu2+ chelator, reversed this effect. In conclusion, our data suggest that copper downregulates the heme synthesis pathway in hepatocellular cells and further reduces it in the presence of mutated ATP7B.


Articles with similar content:

Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor Cells
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Erika Terzuoli, Marina Ziche, Lorenzo Bazzani, Sandra Donnini
5-Aminolevulinic Acid-Mediated Photodynamic Therapy on Hep-2 and MCF-7c3 Cells
Journal of Environmental Pathology, Toxicology and Oncology, Vol.26, 2007, issue 2
Haydee Fukuda, M. S. Lacelli, Maria Gabriela Alvarez, Alcira Batlle, Viviana Rivarola
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 2
Luigi Inguglia, Manuela Labbozzetta, Paola Poma, Monica Notarbartolo, Natale D'Alessandro
The Role of Metallothioneins, Acting Individually and in Mixture, in Detoxification of Cu2+, Zn2+, and Mn2+ in Tissues of the Bivalve Mollusk Anodonta cygnea
Hydrobiological Journal, Vol.40, 2004, issue 5
Ye. V. Mishchuk, R. L. Mykhayliv, O. B. Stoliar
Purification and Characterization of a Novel Protease from the Inky Cap Mushroom, Coprinopsis atramentaria (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 4
Hexiang Wang, Wenwen Chen, Xueran Geng, Tzi Bun Ng, Weiwei Zhang